Mo1248: JOINT IOIBD-ROME CONSENSUS RECOMMENDATIONS FOR THE EVALUATION AND MANAGEMENT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE WITH IRRITABLE BOWEL SYNDROME-LIKE SYMPTOMS
Christopher Ma, Lin Chang(Nanjing Forestry University), Çharles N. Bernstein(University of Manitoba), Giovanni Barbara(University of Bologna), Alexander C. Ford(University of Leeds), Laurie Keefer(Icahn School of Medicine at Mount Sinai), Anne M. Griffiths(University of Toronto), Millie D. Long(University of North Carolina Health Care), Darren M. Brenner(Northwestern University), Jana G. Hashash(Mayo Clinic in Florida), Samuel Nurko(Boston Children's Hospital), Prashant Singh(Michigan Medicine), Bruce E. Sands(Icahn School of Medicine at Mount Sinai)
Cited by 0
Related Papers
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2005|3.9k
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k